Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
09:10:27 02/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0840 AUD | 0.00% |
|
+5.00% | -44.00% |
| Market Cap | 43.12M 30.26M 27.01M 24.79M 22.55M 42.28M 2.86B 296M 119M 1.51B 114M 111M 4.78B | P/E 2027 * |
-3.65x | P/E 2028 * | -12x |
|---|---|---|---|---|---|
| Enterprise Value | 25.22M 17.7M 15.8M 14.5M 13.19M 24.73M 1.68B 173M 69.8M 884M 66.41M 65M 2.79B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 2.08x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATX | Delayed | |
OTC Markets
| INNMF | Delayed |
| 1 week | +5.00% | ||
| 1 month | -26.96% | ||
| 3 months | -35.38% | ||
| 6 months | -44.00% | ||
| Current year | -44.00% |
| 1 week | 0.08 |  | 0.09 |
| 1 month | 0.08 | | 0.12 |
| Current year | 0.08 | | 0.28 |
| 1 year | 0.08 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
Jane Bell
CHM | Chairman | - | 30/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/25 | Exercice | Chairman | 750,000 | 0.1933% | ||
| 08/09/25 | Free | Founder | 447,000 | 0.1152% | ||
| 08/09/25 | Exercice | Director | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +5.00% | -40.00% | -1.18% | 30.34M | |
| -2.37% | -4.19% | +39.49% | +63.21% | 63.77B | |
| -2.87% | +0.49% | +10.45% | +69.18% | 56.37B | |
| +0.62% | +2.11% | +20.22% | +102.56% | 54.62B | |
| -2.65% | -4.72% | +21.89% | +36.88% | 44.06B | |
| -1.50% | -1.94% | +16.61% | +99.76% | 42.11B | |
| -0.96% | +2.68% | +218.27% | +792.81% | 41B | |
| -5.47% | +24.76% | +98.34% | +87.34% | 34.92B | |
| +0.21% | -1.23% | +14.81% | +47.35% | 32.82B | |
| -1.65% | +18.45% | -40.64% | +342.00% | 24.7B | |
| Average | -1.65% | +7.45% | +35.94% | +163.99% | 39.44B | |
| Weighted average by Cap. | -1.82% | +5.64% | +44.98% | +164.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.67M 5.95M 5.46M 4.97M 9.31M 631M 65.23M 26.29M 333M 25.02M 24.49M 1.05B |
| Net income | -11.6M -8.14M -7.27M -6.67M -6.07M -11.37M -771M -79.65M -32.11M -407M -30.55M -29.9M -1.28B | -4.1M -2.88M -2.57M -2.36M -2.14M -4.02M -272M -28.15M -11.35M -144M -10.8M -10.57M -454M |
| Net Debt | -17.9M -12.56M -11.21M -10.29M -9.36M -17.55M -1.19B -123M -49.54M -628M -47.14M -46.14M -1.98B | -23.4M -16.42M -14.66M -13.45M -12.24M -22.94M -1.55B -161M -64.77M -820M -61.63M -60.31M -2.59B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | A$0.0840 | 0.00% | 736,376 |
| 30/10/26 | A$0.0840 | -5.62% | 1,154,303 |
| 29/10/26 | A$0.0890 | +7.23% | 602,933 |
| 28/10/26 | A$0.0830 | +5.06% | 339,346 |
| 27/10/26 | A$0.0790 | +1.28% | 315,976 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0840AUD
Average target price
0.4200AUD
Spread / Average Target
+400.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
